Solmaz Norouzi

Solmaz Norouzi

Auto-generated profile, based on publicly available information

Solmaz Norouzi

Metabolic Diseases Research Center, Health and Metabolic DiseasesResearch Institute, Zanjan University of Medical Sciences, Zanjan, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2025 in Health Promotion Perspectives
Verified
Journal Article
Open access
PDF file
SNSolmaz Norouzi
Solmaz Norouzi
SASamira Ahmadi
Samira Ahmadi
SAShayeste Alinia
Shayeste Alinia
FFFarshid Farzipoor
Farshid Farzipoor
ASAzadeh Shahsavari
Azadeh Shahsavari
MAMohammad Asghari Asghari-Jafarabadi
Mohammad Asghari Asghari-Jafarabadi
Background: This study aims to harness the predictive power of machine learning (ML) algorithms for accurately predicting mortality and survival outcomes in brain stroke (BS) patients. Methods: A total of 332 patients diagnosed with BS were enrolled in the study between April 21, 2006, and December 22, 2007, and then followed for 15 years (until 2023). Mortality outcomes were modeled using various statistical techniques, including the Cox model, decision trees, random survival forests (RSF), support vector machines (SVM), gradient boosting, and mboost. The best-performing model was selected based on diagnostic performance metrics: specificity, sensitivity, precision, accuracy, area under the receiver operating characteristic curve (AUC), positive likelihood ratio, negative likelihood ratio, and negative predictive value. Results: The results indicate that ML models in small sample sizes, particularly the SVM, outperformed the Cox model in predicting mortality and survival over 15 years, achieving an accuracy of 85% and an AUC of 0.765 (95% CI 0.637-0.83). Furthermore, the study identified important variables, including blood pressure history, waterpipe smoking, lack of physical activity, type of cerebrovascular accident, current smoking status, sex, and age, which provide valuable insights for clinicians in risk assessment. Conclusion: Our study showed that the SVM model outperforms the Cox model in predicting 15-year mortality and survival, particularly in small sample sizes. Moreover, the identification of key risk factors such as blood pressure history, waterpipe smoking, lack of physical activity, type of cerebrovascular accident, current smoking status, sex, and age highlights the need for their consideration in clinical assessments to enhance patient care.

24 February 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
MKMahnaz Kayyal
Mahnaz Kayyal
SASamira Ahmadi
Samira Ahmadi
GSGholamreza Sadeghi
Gholamreza Sadeghi
ERElham Rasoulian-Barzoki
Elham Rasoulian-Barzoki
SNSolmaz Norouzi
Solmaz Norouzi
MJMohammadamin Jandaghian-Bidgoli
Mohammadamin Jandaghian-Bidgoli
Gestational diabetes mellitus (GDM) affects a significant proportion of pregnant women, impacting both physical and psychological well-being. This study aimed to investigate the factors influencing quality of life (QoL) in women with GDM. This systematic review followed PRISMA guidelines and was registered in PROSPERO (ID: CRD42024612587). A comprehensive search was conducted in PubMed, Scopus, ProQuest, Web of Science, and CINAHL, using MeSH terms related to gestational diabetes and quality of life. Eligible studies included adult women with gestational diabetes and assessed factors influencing their quality of life. The included studies were related to various stages including antenatal, during pregnancy or postpartum. Data extraction was performed independently by two authors, and study quality was evaluated using the Newcastle-Ottawa Scale (NOS). Statistical analyses were conducted in STATA, including meta-analysis with a random-effects model. The findings reveal that women with GDM experience significantly lower QoL compared to healthy pregnant women, with sexual dysfunction being a notable contributor. Women with GDM reported lower sexual desire, satisfaction, and higher pain levels, which were significantly associated with poorer QoL, particularly in mental health and pain domains. Socio-demographic factors such as age, education, income, and marital status were significantly linked to QoL, with younger women and those with lower education or income reporting poorer outcomes. Psychological factors, including stress, depression, and anxiety, negatively impacted QoL, while social support, self-efficacy, and illness acceptance were positively correlated with better QoL outcomes. Additionally, stress was found to be the main predictor of QoL for women over 30, while social relationships were more important for younger women. Treatment with insulin or a combination of insulin and oral hypoglycemic agents was associated with lower QoL compared to dietary management alone. This systematic review identified key psychosocial and medical factors influencing the quality of life in women with gestational diabetes. The findings emphasize the importance of addressing psychological well-being, social support, and treatment approaches to enhance QoL in these women. Further research is needed to explore interventions targeting mental health and stress management to improve outcomes for women with gestational diabetes.

31 January 2021 in Journal of Preventive Medicine and Public Health
Verified
Journal Article
Open access
PDF file
SNSolmaz Norouzi
Solmaz Norouzi
MAMohammad Asghari Asghari-Jafarabadi
Mohammad Asghari Asghari-Jafarabadi
SEYEDREZA SHAMSHIRGARANSEYEDREZA SHAMSHIRGARAN
SEYEDREZA SHAMSHIRGARAN
FFFarshid Farzipoor
Farshid Farzipoor
RFRamazan Fallah
Ramazan Fallah
After heart disease, brain stroke (BS) is the second most common cause of death worldwide, underscoring the importance of understanding preventable and treatable risk factors for the outcomes of BS. This study aimed to model the survival of patients with BS in the presence of competing risks. This longitudinal study was conducted on 332 patients with a definitive diagnosis of BS. Demographic characteristics and risk factors were collected by a validated checklist. Patients' mortality status was investigated by telephone follow-up to identify deaths that may be have been caused by stroke or other factors (heart disease, diabetes, high cholesterol, etc.). Data were analyzed by the Lunn-McNeil approach at alpha=0.1. Older age at diagnosis (59-68 years: adjusted hazard ratio [aHR], 2.19; 90% confidence interval [CI], 1.38 to 3.48; 69-75 years: aHR, 5.04; 90% CI, 3.25 to 7.80; ≥76 years: aHR, 5.30; 90% CI, 3.40 to 8.44), having heart disease (aHR, 1.65; 90% CI, 1.23 to 2.23), oral contraceptive pill use (women only) (aHR, 0.44; 90% CI, 0.24 to 0.78) and ischemic stroke (aHR, 0.52; 90% CI, 0.36 to 0.74) were directly related to death from BS. Older age at diagnosis (59-68 years: aHR, 21.42; 90% CI, 3.52 to 130.39; 75-69 years: aHR, 16.48; 90% CI, 2.75 to 98.69; ≥76 years: aHR, 26.03; 90% CI, 4.06 to 166.93) and rural residence (aHR, 2.30; 90% CI, 1.15 to 4.60) were directly related to death from other causes. Significant risk factors were found for both causes of death. BS-specific and non-BS-specific mortality had different risk factors. These findings could be utilized to prescribe optimal and specific treatment.

25 November 2025 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
FAFatemeh Abbasi
Fatemeh Abbasi
MRMasome Rahimi
Masome Rahimi
ZSZahra Sedighifar
Zahra Sedighifar
SNSolmaz Norouzi
Solmaz Norouzi
MJMohammadamin Jandaghian-Bidgoli
Mohammadamin Jandaghian-Bidgoli
SASamira Ahmadi
Samira Ahmadi
Suicide prevention remains a critical public health priority, with internet-based interventions offering accessible and scalable solutions. These digital a

1 March 2020 in Jorjani Biomedicine Journal
Verified
Journal Article
Closed access
PDF file
SNSayede Shadi Nazari
Sayede Shadi Nazari
SNSolmaz Norouzi
Solmaz Norouzi
MJMohammad Asghari Jafar-Abadi
Mohammad Asghari Jafar-Abadi
DSDepartment of Zanjan University of Medical Sciences.
Department of Zanjan University of Medical Sciences.
Background and objective: Prevalence and the spread of novel Coronavirus (2019-ncov) cause significant life and financial destruction worldwide and is the cause of severe respiratory infection in humans. The present study briefly reviews the latest information on how the virus is distributed around the world. The main question of the ...

22 May 2026 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
MSMina Shojaee
Mina Shojaee
MSMahsa Sharifnejad
Mahsa Sharifnejad
NANastaran Safavi Ardabili
Nastaran Safavi Ardabili
FAfatemeh abdi
fatemeh abdi
MJMohammadamin Jandaghian-Bidgoli
Mohammadamin Jandaghian-Bidgoli
SNSolmaz Norouzi
Solmaz Norouzi
Gestational diabetes mellitus (GDM) is a prevalent condition with significant maternal and fetal health implications. Lifestyle education is a promising non-pharmacological intervention to improve quality of life (QoL) and FBG (FBG) in affected women. For the purposes of this review, lifestyle education interventions are defined as structured programs including dietary counseling, physical activity guidance, and/or self-management education (e.g., blood glucose monitoring), delivered through planned sessions with defined frequency, duration, and content. This systematic review and meta-analysis evaluates its efficacy. A comprehensive search of PubMed, Embase, Cochrane CENTRAL, Scopus, and Web of Science was conducted up to October 2025, following PRISMA guidelines. Studies were included if they involved women with GDM, evaluated lifestyle education (structured, curriculum-based programs with multiple sessions, specified learning objectives, and follow-up components), and reported QoL or FBG outcomes. Randomized controlled trials and quasi-experimental studies with comparators were eligible. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Cochrane tool. Meta-analyses used a random effects model, with heterogeneity assessed via I² statistics. Subgroup analyses explored intervention types, and publication bias was evaluated using Egger's and Begg's tests. From 304 records identified, 20 studies (19 randomized controlled trials and 1 quasi-experimental study) involving 4,777 women were included. Overall meta-analysis demonstrated a statistically significant effect of lifestyle interventions on quality of life and fasting blood glucose (FBG) outcomes (Hedges' g = - 0.31, 95% CI: -0.57 to - 0.05, p = 0.02), although substantial heterogeneity was observed (I² = 91.94%). For FBG outcomes, the overall pooled effect estimate was - 4.01 mg/dL (95% CI: -8.13 to 0.10), with high heterogeneity (I² = 97.42%). Subgroup analyses showed that combined individual and group-based interventions significantly reduced FBG levels (pooled effect estimate = - 2.60 mg/dL, 95% CI: -4.90 to - 0.31; I² = 0%), whereas individual-only and group-only interventions were not statistically significant. For quality of life outcomes, the overall pooled effect was not statistically significant (pooled effect estimate = 3.42, 95% CI: -0.55 to 7.39; I² = 91.28%). Exploratory subgroup analyses indicated that combined interventions significantly improved quality of life (pooled effect estimate = 5.20, 95% CI: 3.76 to 6.64; I² = 0%), while standalone individual and group interventions showed no statistically significant effects. Egger's (p = 0.12) and Begg's (p = 0.19) tests suggested no significant publication bias. Sensitivity analyses confirmed the robustness of the findings. Lifestyle education interventions effectively reduce FBG in women with GDM, with group and combined interventions showing most consistent benefits. However, the impact on QoL remains uncertain; while combined individual and group approaches showed some promise in exploratory subgroup analyses, the overall pooled effect on QoL was non-significant with substantial heterogeneity. These subgroup findings should be considered hypothesis-generating rather than definitive. Tailored, scalable interventions integrating individual and group components may optimize GDM management, but further high-quality research is needed to confirm efficacy for QoL improvement.